Debate continues over study of intraoperative rad therapy for breast cancer

A study published last year in the Lancet showing the merits of treating breast cancer with intraoperative radiation therapy (IORT) offered hope that the technique could be a safer alternative to traditional treatment. But not everybody is convinced.

The randomized controlled trial found IORT could prevent cancer from returning while also limiting the side effects seen with lengthier traditional treatments. However, some have criticized the design of the study and others say traditional radiation does a better job of controlling recurrence.

The Wall Street Journal checks in on the debate at the link below:

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.